Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats

被引:60
作者
Kuter, Katarzyna
Smialowska, Maria
Wieronska, Joanna
Zieba, Barbara
Wardas, Jadwiga
Pietraszek, Malgorzata
Nowak, Przemyslaw
Biedka, Izabela
Roczniak, Wojciech
Konieczny, Jolanta
Wolfarth, Stanislaw
Ossowska, Krystyna
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Neuropsychopharmacol, PL-31343 Krakow, Poland
[2] Polish Acad Sci, Inst Pharmacol, Dept Neurobiol, PL-31343 Krakow, Poland
[3] L Warynski Silesian Med Acad, Dept Pharmacol, PL-41808 Zabrze, Poland
关键词
Parkinson's disease; paraquat; degeneration; dopaminergic neurons; GAD67; mRNA; proenkephalin mRNA;
D O I
10.1016/j.brainres.2007.04.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Paraquat is a toxin suggested to contribute to pathogenesis of Parkinson's disease. The aim of the present study was to examine toxic influence of subchronic treatment with this pesticide (5 days, one injection per day, 2-3 days of withdrawal) on dopaminergic, serotonergic, noradrenergic and GABAergic neurons. Paraquat decreased the number of tyrosine hydroxylase-immunoreactive (TH-ir) neurons in the substantia nigra by 22% (measured 3 days after withdrawal). Two days after withdrawal the levels of the dopamine metabolites and dopamine turnover in the caudate-putamen, substantia nigra and prefrontal cortex were reduced by ca. 20-60%, and the binding of [H-3]GBR 12,935 to dopamine transporter dropped by 25-40% in the caudate-putamen. Three days after paraquat withdrawal, the level of dopamine in the caudate-putamen was significantly increased, and earlier decreases in DOPAC and HVA in the substantia nigra, as well as [H-3]GBR 12,935 binding in the caudate-putamen were reversed. Moreover, an increase in serotonin turnover in the caudate-putamen and prefrontal cortex, and noradrenaline level in the former structure was observed 2-3 days after paraquat withdrawal. Three days after the last paraquat injection 24-35% decreases in the proenkephalin mRNA levels and 5-7% reduction in glutamic acid decarboxylase (GAD)67 mRNA were found in the caudate-putamen. The present study suggests that subchronic paraquat administration triggers processes characteristic of early stages of dopaminergic neuron degeneration, and activates compensatory mechanisms involving dopaminergic, noradrenergic, serotonergic and GABAergic transmissions. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:196 / 207
页数:12
相关论文
共 62 条
[1]   123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy [J].
Antonini, A ;
Benti, R ;
De Notaris, R ;
Tesei, S ;
Zecchinelli, A ;
Sacilotto, G ;
Meucci, N ;
Canesi, M ;
Mariani, C ;
Pezzoli, G ;
Gerundini, P .
NEUROLOGICAL SCIENCES, 2003, 24 (03) :149-150
[2]   Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease [J].
Asanuma, M ;
Miyazaki, I ;
Ogawa, N .
NEUROTOXICITY RESEARCH, 2003, 5 (03) :165-176
[3]   H2O2 signaling in the nigrostriatal dopamine pathway via ATP-sensitive potassium channels:: Issues and answers [J].
Avshalumov, Marat V. ;
Bao, Li ;
Patel, Jyoti C. ;
Rice, Margaret E. .
ANTIOXIDANTS & REDOX SIGNALING, 2007, 9 (02) :219-231
[4]   Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: A microdialysis study [J].
Balcioglu, A ;
Zhang, K ;
Tarazi, FI .
NEUROSCIENCE, 2003, 119 (04) :1045-1053
[5]   Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates [J].
Barlow, BK ;
Thiruchelvam, MJ ;
Bennice, L ;
Cory-Slechta, DA ;
Ballatori, N ;
Richfield, EK .
JOURNAL OF NEUROCHEMISTRY, 2003, 85 (04) :1075-1086
[6]   Presymptomatic compensation in Parkinson's disease is not dopamine-mediated [J].
Bezard, E ;
Gross, CE ;
Brotchie, JM .
TRENDS IN NEUROSCIENCES, 2003, 26 (04) :215-221
[7]   Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss [J].
Brooks, AI ;
Chadwick, CA ;
Gelbard, HA ;
Cory-Slechta, DA ;
Federoff, HJ .
BRAIN RESEARCH, 1999, 823 (1-2) :1-10
[8]   Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats [J].
Carta, AR ;
Pinna, A ;
Cauli, O ;
Morelli, M .
SYNAPSE, 2002, 44 (03) :166-174
[9]   Dopaminergic cell death induced by MPP+, oxidant and specific neurotoxicants shares the common molecular mechanism [J].
Chun, HS ;
Gibson, GE ;
DeGiorgio, LA ;
Zhang, H ;
Kidd, VJ ;
Son, JH .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (04) :1010-1021
[10]   Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats [J].
Cicchetti, F ;
Lapointe, N ;
Roberge-Tremblay, A ;
Saint-Pierre, M ;
Jimenez, L ;
Ficke, BW ;
Gross, RE .
NEUROBIOLOGY OF DISEASE, 2005, 20 (02) :360-371